Aida on Nostr: Novartis has been focusing on rare diseases for the last 10 or more years. I'm sure ...

Novartis has been focusing on rare diseases for the last 10 or more years. I'm sure other pharmaceutical companies are doing the same. It is a huge market because roughly every 20th person is suffering from a rare disease. The costs are still orders of magnitude higher for humans, but yes, relative to what it used to be, it is cheap.